The low borosilicate glass tube market is experiencing robust growth, driven by increasing demand from pharmaceutical and laboratory applications. The market, estimated at $2.5 billion in 2025, is projected to expand significantly over the forecast period (2025-2033), fueled by a compound annual growth rate (CAGR) of approximately 7%. This growth is primarily attributed to the inherent properties of low borosilicate glass, such as its high chemical resistance, thermal stability, and clarity, making it ideal for applications requiring precise measurements and containment of sensitive materials. The pharmaceutical industry, a major consumer, is adopting low borosilicate glass tubes extensively for drug delivery systems, vial manufacturing, and ampoules. Furthermore, the growing healthcare sector and increasing research and development activities in the life sciences domain further bolster market demand. Transparent tubes dominate the market share, reflecting the need for clear visibility in laboratory settings and pharmaceutical applications for visual inspection.